Predictors of diagnosis and symptom perception in GORD/LPR

  • Research type

    Research Study

  • Full title

    Psychological predictors of diagnosis and symptom perception in gastro-oesophageal and laryngo-pharyngeal reflux disease

  • IRAS ID

    118530

  • Contact name

    Robert Horne

  • Contact email

    R.Horne@ucl.ac.uk

  • Sponsor organisation

    University College London

  • Research summary

    Gastro-oesophageal reflux disease (GORD) and laryngo-pharyngeal reflux disease (LPR) are caused by an increase in acid within the gullet. Some individuals, however, experience GORD and LPR-like symptoms in the absence of abnormal pH. Patients who do experience symptoms, such as heartburn due to abnormal pH within the gullet, and respond to treatment are termed true responders. Those who experience symptoms due to normal changes in pH are termed hypersensitive, whereas others who experience symptoms that do not relate to normal changes in pH are considered to have functional heartburn. Hypersensitive patients and those with functional heartburn seem to respond less well to current medication.

    The present study aims to predict whether patients are true responders, hypersensitive patients and functional heartburn patients, as assessed using self-reported symptoms and a 24-hour impedance-pH test, using a number of psychological predictors. Secondly, the study aims to assess whether these subgroups of patients differ in their response to different messages about treatment effectiveness, as assessed through a modified Bernstein Test. In this test, two saline solutions will be perfused consecutively in the gullet, however, different information will be provided about each solution (beneficial or neutral).

    Logistic regression will be used to determine whether differences in psychological variables predict diagnosis test outcome. Regression analysis will be used to determine relationships between psychological variables and 1) pain perception during the modified Bernstein test, 2) reported benefit from current PPI treatment.

    Results from this study may inform the diagnostic process, allow doctors to make quicker decisions about treatment and identify those patients who may benefit more from alternative therapies such as cognitive behavioural therapy.

  • REC name

    London - Queen Square Research Ethics Committee

  • REC reference

    14/LO/0593

  • Date of REC Opinion

    22 May 2014

  • REC opinion

    Further Information Favourable Opinion